Vivimed Labs launches Covid-19 drug Favulous in India
Vivimed Labs has launched Favulous, its generic version of Covid-19 drug Favipiravir Tablet 200 mg and 400 mg in India. The launch follows the approval ... Read More
Glenmark Pharmaceuticals launches FabiFlu for COVID-19 treatment in India
Glenmark Pharmaceuticals has secured approval from India to launch Japan-based Fujifilm's antiviral drug favipiravir under the brand name FabiFlu for the treatment of COVID-19 in ... Read More